HanAll Biopharma kept up its sales growth last year, but annual operating profit swung to a loss due to higher selling, general and administrative costs. HanAll Biopharma said on the 21st in a ...

In 2023, Teva made a pledge to bolster its innovative medicines portfolio without leaving behind its century-long legacy as a leading generics drugmaker. Now with its innovative drug franchise ...

Logos are more than just a stylish symbol on the hood of a car; they are intrinsically tied to the brand they represent, and many of us come to recognize them immediately. In fact, children can often ...

Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

After almost a decade of research and development, Singapore-based iX Biopharma is starting to see its long-term bet pay off. The company, founded in 2008 and currently listed on SGX’s Catalist board, ...

HanAll Biopharma continued revenue growth last year, but annual operating profit turned to a loss due to higher selling and administrative expenses. HanAll Biopharma said on the 21st in a preliminary ...

Agomab Therapeutics and SpyGlass Pharma secured a combined $350 million in two separate initial public offerings on Thursday ...

Can an athlete logo contain multitudes? Can a monochromatic mark somehow capture all the glory of a basketball player’s achievements, the verve of a charismatic tennis star, or celly after a scored ...